Jamila Hokanson, MBA, MS, MD

Dr. Hokanson attended medical school at the University of Texas Southwestern Medical Center and completed psychiatry residency at Yale University Department of Psychiatry where she was a Program-wide Chief Psychiatry Resident and Chief Resident of the Clinical Neuroscience Research Unit. She has a background in medicine, business management, and quality improvement. She has led global and community organizational change initiatives, including local and national non-profit startups aimed at addressing education and health disparities. Her clinical interests include working with adolescents and young adults healing from trauma, supporting research in psychedelic assisted psychotherapy with a particular focus on people of color and young adults, and leveraging integrative psychiatry treatment modalities. She was a 2021 fellow of the integrative psychiatry institute. She currently is a trainee for MAPS-sponsored MDMA-assisted psychotherapy for the treatment of PTSD, and a Yale research study psychiatrist for Psilocybin-assisted psychotherapy for the treatment of OCD and Depression.